논문KCI 등재
Comments on the Published Meta-Analysis of Clinical and Microbiologic Efficacy and Safety of Imipenem/Cilastatin/Relebactam in Complicated Infections
2
조회
0
다운로드
0
인용
0
참고문헌
주제분류내과학
참고문헌 (2)
- Syeda Sahra, "Clinical and Microbiologic Efficacy and Safety of Imipenem", Cilastatin, Infection and Chemotherapy, pp.2021, 53(2)[DOI]
- Motsch J, "RESTORE-IMI 1: a multicenter, randomized, double-blind trial comparing efficacy and safety of imipenem", relebactam vs colistin plus imipenem in patients with imipenem-nonsusceptible bacterial infections, 2020, pp.70, 1799~1808
관련 논문AI추천
Reply: Comments on the Published Meta-Analysis of Clinical and Microbiologic Efficacy and Safety of Imipenem/Cilastatin/Relebactam in Complicated InfectionsAbdullah Jahangir, Syeda Sahra대한감염학회 · Infection and Chemotherapy2021 · 제53권 제3호Clinical and Microbiologic Efficacy and Safety of Imipenem/Cilastatin/Relebactam in Complicated Infections: A Meta-analysisAbdullah Jahangir, Ahmad Jahangir, Allison Glaser, Rachelle Hamadi, Syeda Sahra대한감염학회 · Infection and Chemotherapy2021 · 제53권 제2호Reply: The Efficacy of Penicillins with β-lactamase Inhibitor or Cefmetazole against Pneumonia in which ESBL-Producing Bacteria were Isolated from SputumKang Cheol-In대한감염학회 · Infection and Chemotherapy2021 · 제53권 제3호Comparison of Efficacy of Cefoperazone/Sulbactam and Imipenem/Cilastatin for Treatment of Acinetobacter Bacteremia김명수, 김연아, 김영근, 김준명, 김창오, 박윤선, 송영구, 신소연, 용동은, 윤희정, 이경원, 최준용연세대학교의과대학 · Yonsei Medical Journal2006 · 제47권 제1호The First Case of Septicemia Caused by Imipenem-Susceptible, Meropenem-Resistant Klebsiella pneumoniaeHiroki Ohge, Kentaro Imon, Makoto Onodera, Michiya Yokozaki, Motoyuki Sugai, Norifumi Shigemoto, Ryuichi Kuwahara, Shizuo Kayama, Takashi Ishino대한진단검사의학회 · Annals of Laboratory Medicine2013 · 제33권 제5호Reply: Antimicrobial Stewardship at the End of Life: From Overtreatment to Responsible PracticeAlwazzeh Marwan Jabr대한감염학회 · Infection and Chemotherapy2025 · 제57권 제4호
이 간행물의 다른 논문 (24건)
Report of the Korean Society of Infectious Diseases Roundtable Discussion on Responses to the Measles Outbreaks in Korea in 2019Jeong Hye Won, Jee Youngmee, Choi Eun Hwa, Jo Soo-Nam, Jung Hyungul, Lee Mi Suk, Kim Min Ja, Kim Kwang Nam, Kim Sung-Han, Kim Yang Soo, Seok Hyeri, Park Se Yoon, Choi Young Hwa, Chin Bum Sik, Park Su Eun, Eun Byung Wook, Park Dae Won, Choi Hee Jung, Kim Jeong Yeon, 장현하pp. 405-420Core Elements for Successful Implementation of Antimicrobial Stewardship Programs권기태, Hwang Soyoonpp. 421-435Ruxolitinib and the Mitigation of Severe COVID-19: A Systematic Review and Meta-analysisAbdulhusein Kapasi, Jorge R. Quiros, Jennifer Ross-Comptis, Donald Hathaway, Azza Sarfraz, Zouina Sarfraz, Zhanna Grigoryan, Kimberly Anne Romero, Abubakar Gapizov, Fortunato S Príncipe-Meneses, Manoj Reddy Somagutta, Adrian Riva-Moscosopp. 436-448Evolution of Antimicrobial Resistance Levels of ESKAPE Microorganisms in a Peruvian IV-Level HospitalNayade Rojas, Roger Albornoz, Nestor Luque, Wilfredo Flores-Paredes, Joaquim Ruiz, Maria J. Pons, Manuel Espinozapp. 449-462Significance and Associated Factors of Long-Term Sequelae in Patients after Acute COVID-19 Infection in KoreaKwon Ki Tae, Bae Sohyun, Hwang Soyoon, 장현하, 김신우, Kim Yoonjungpp. 463-476